Prelude Therapeutics Incorporated (PRLD) News
Track canonical SquawkNews coverage tagged to PRLD, Prelude Therapeutics Incorporated. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Prelude Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
Prelude Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results.
EARNINGS | Aug 11, 2026, 07:18 PM UTC
H
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Tuesday. Shares of Sherwin-Williams Co (NYSE: SHW ) rose sharply after the company reported better-than-expected second-quarter financial resu
EARNINGS | Jul 28, 2026, 02:05 PM UTC
L
PRLD +20% in pre-mkt INCY - Prelude Therapeutics shares are higher in pre-mkt after Incyte discontinues further development of INCB160058. [
PRLD +20% in pre-mkt INCY - Prelude Therapeutics shares are higher in pre-mkt after Incyte discontinues further development of INCB160058. [Prelude Therapeutics' corresponding drug candidate is PRT12396, a mutant-selecti
EQUITY | Jul 28, 2026, 12:53 PM UTC